SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001711279-23-000059
Filing Date
2023-07-03
Accepted
2023-07-03 16:35:23
Documents
1
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1688416510.html 4  
1 FORM 4 wk-form4_1688416510.xml 4 3829
  Complete submission text file 0001711279-23-000059.txt   5227
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Issuer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701 PITTSBURGH PA 15203
Business Address
Mazzacco Catherine (Reporting) CIK: 0001967722 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38210 | Film No.: 231065621